Penserra Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,764
| Closed | -$19K | – | 1221 |
|
|
2024
Q3 | $19K | Sell |
1,764
-127
| -7% | -$1.37K | ﹤0.01% | 869 |
|
|
2024
Q2 | $18K | Buy |
1,891
+70
| +4% | +$666 | ﹤0.01% | 914 |
|
|
2024
Q1 | $59K | Sell |
1,821
-444
| -20% | -$14.4K | ﹤0.01% | 861 |
|
|
2023
Q4 | $60K | Hold |
2,265
| – | – | ﹤0.01% | 972 |
|
|
2023
Q3 | $136K | Sell |
2,265
-2,222
| -50% | -$133K | ﹤0.01% | 832 |
|
|
2023
Q2 | $457K | Buy |
4,487
+34
| +0.8% | +$3.46K | 0.01% | 554 |
|
|
2023
Q1 | $787K | Sell |
4,453
-449
| -9% | -$79.4K | 0.02% | 425 |
|
|
2022
Q4 | $1.9M | Buy |
4,902
+77
| +2% | +$29.8K | 0.04% | 362 |
|
|
2022
Q3 | $1.63M | Sell |
4,825
-694
| -13% | -$234K | 0.05% | 297 |
|
|
2022
Q2 | $1.81M | Buy |
5,519
+267
| +5% | +$87.8K | 0.05% | 306 |
|
|
2022
Q1 | $2.3M | Sell |
5,252
-45
| -0.8% | -$19.7K | 0.05% | 319 |
|
|
2021
Q4 | $2.32M | Sell |
5,297
-78
| -1% | -$34.2K | 0.05% | 345 |
|
|
2021
Q3 | $2.99M | Sell |
5,375
-1,538
| -22% | -$855K | 0.06% | 298 |
|
|
2021
Q2 | $3.55M | Sell |
6,913
-1,746
| -20% | -$897K | 0.06% | 294 |
|
|
2021
Q1 | $6.77M | Buy |
8,659
+5,487
| +173% | +$4.29M | 0.13% | 190 |
|
|
2020
Q4 | $1.73M | Buy |
3,172
+1,341
| +73% | +$730K | 0.04% | 271 |
|
|
2020
Q3 | $837K | Sell |
1,831
-1
| -0.1% | -$457 | 0.03% | 282 |
|
|
2020
Q2 | $1.13M | Buy |
1,832
+270
| +17% | +$166K | 0.06% | 237 |
|
|
2020
Q1 | $741K | Buy |
1,562
+1,302
| +501% | +$618K | 0.05% | 314 |
|
|
2019
Q4 | $152K | Sell |
260
-14
| -5% | -$8.19K | 0.01% | 506 |
|
|
2019
Q3 | $180K | Buy |
+274
| New | +$180K | 0.02% | 408 |
|